Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis is a research paper published in PharmacoEconomics - Open (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: OTA OT3HL152448
National Institutes of Health
Grant: OTA OT3HL151434
NHLBI NIH HHS
Grant: OT3 HL151434
NHLBI NIH HHS
Grant: OT3 HL152448
National Institutes of Health
Grant: 6OT3HL151434-02
The Cure Sickle Cell Initiative Economic Analysis: An Evaluation of the Costs of Sickle Cell Disease and Potential Health Plan Budget Impacts of Gene Therapy as a New Treatment Option
National Institutes of Health
Grant: 1OT3HL152448-01
Model for Economic Analysis of Sickle cell cURE (MEASURE)
FWCI
2.41
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords